{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:43:36Z","timestamp":1791330216679,"version":"4.3.1"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09814-w","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T10:02:55Z","timestamp":1723456975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight"],"prefix":"10.1007","volume":"51","author":[{"given":"Shaukat","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Summer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnoor","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzeen","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiba","family":"Nazakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"9814_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5455\/jabet.2023.d103","volume":"6","author":"S Islam","year":"2023","unstructured":"Islam S, Nobel FA, Sabrina S, Islam A, Islam MJ (2023) Assessment and comparison of cardiovascular disease risk factors and biochemical parameters among men and women: a cross-sectional study. J Adv Biotechnol Exp Ther 6:25\u201334","journal-title":"J Adv Biotechnol Exp Ther"},{"key":"9814_CR2","first-page":"e96","volume":"46","author":"P Ordunez","year":"2023","unstructured":"Ordunez P, Campbell NR, Giraldo Arcila GP et al (2023) HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care. Revista Panam De Salud P\u00fablica 46:e96","journal-title":"Revista Panam De Salud P\u00fablica"},{"key":"9814_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2022.07.003","volume":"49","author":"A S\u00f6dergren","year":"2023","unstructured":"S\u00f6dergren A, Rantap\u00e4\u00e4-Dahlqvist S, Ljung L (2023) Time trends of cardiovascular disease in the general population and inflammatory arthritis. Rheumatic Disease Clin 49:1\u201317","journal-title":"Rheumatic Disease Clin"},{"key":"9814_CR4","doi-asserted-by":"crossref","unstructured":"Lang F, Schmidt RF (2005) Physiologie Des Menschen. Springer Medizin Verlag Heidelberg","DOI":"10.1007\/b137547"},{"key":"9814_CR5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.9734\/jpri\/2021\/v33i57B34046","volume":"33","author":"A Khan","year":"2021","unstructured":"Khan A, Butt MZI, Khan S et al (2021) Exercise as an emerging factor effecting Cardiovascular Health (An Experimental Approach). J Pharm Res Int 33:193\u2013205","journal-title":"J Pharm Res Int"},{"key":"9814_CR6","doi-asserted-by":"crossref","first-page":"102084","DOI":"10.1016\/j.cpcardiol.2023.102084","volume":"49","author":"SU Khan","year":"2024","unstructured":"Khan SU, Khan SU, Suleman M et al (2024) Natural allies for Heart Health: Nrf2 activation and Cardiovascular Disease Management. Curr Probl Cardiol 49:102084","journal-title":"Curr Probl Cardiol"},{"key":"9814_CR7","doi-asserted-by":"crossref","unstructured":"Ferreir JL, Kumar S, Soni A, Acharya N, Acharya S (2023) Clinical Management of Cardiovascular diseases; in current trends in the diagnosis and management of metabolic disorders 254\u2013278. CRC","DOI":"10.1201\/9781003384823-15"},{"key":"9814_CR8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/ijms25021001","volume":"25","author":"A Scafa Udri\u0219te","year":"2024","unstructured":"Scafa Udri\u0219te A, Burdu\u0219el AC, Niculescu A-G, R\u0103dulescu M, Grumezescu AM (2024) Metal-based nanoparticles for Cardiovascular diseases. Int J Mol Sci 25:1001","journal-title":"Int J Mol Sci"},{"key":"9814_CR9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.24925\/turjaf.v7i4.684-687.2486","volume":"7","author":"B \u00d6zaltun","year":"2019","unstructured":"\u00d6zaltun B, Selamo\u011flu Z (2019) Affinity of Propofol to Human serum Albumin and Cardiovascular effects. Turkish J Agriculture-Food Sci Technol 7:684\u2013687","journal-title":"Turkish J Agriculture-Food Sci Technol"},{"key":"9814_CR10","doi-asserted-by":"crossref","unstructured":"Ozaltun B, Selamoglu Z (2019) Zooplankton and their protective effects on cardiovascular diseases. J Surv Fisheries Sci, 99\u2013105","DOI":"10.18331\/SFS2019.6.1.10"},{"key":"9814_CR11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","volume":"60","author":"LJ Laslett","year":"2012","unstructured":"Laslett LJ, Alagona P, Clark BA et al (2012) The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol 60:S1\u2013S49","journal-title":"J Am Coll Cardiol"},{"key":"9814_CR12","first-page":"e006512","volume":"13","author":"M Fudim","year":"2020","unstructured":"Fudim M, Hopley CW, Huang Z et al (2020) Association of hypertension and arterial blood pressure on limb and cardiovascular outcomes in symptomatic peripheral artery disease: the EUCLID trial. Circulation: Cardiovasc Qual Outcomes 13:e006512","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"key":"9814_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","volume":"129","author":"SE Kjeldsen","year":"2018","unstructured":"Kjeldsen SE (2018) Hypertension and cardiovascular risk: General aspects. Pharmacol Res 129:95\u201399","journal-title":"Pharmacol Res"},{"key":"9814_CR14","doi-asserted-by":"crossref","first-page":"105041","DOI":"10.1016\/j.ijmedinf.2023.105041","volume":"173","author":"M Pelly","year":"2023","unstructured":"Pelly M, Fatehi F, Liew D, Verdejo-Garcia A (2023) Artificial intelligence for secondary prevention of myocardial infarction: a qualitative study of patient and health professional perspectives. Int J Med Informatics 173:105041","journal-title":"Int J Med Informatics"},{"key":"9814_CR15","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1161\/CIRCULATIONAHA.105.591792","volume":"112","author":"TA Gaziano","year":"2005","unstructured":"Gaziano TA (2005) Cardiovascular disease in the developing world and its cost-effective management. Circulation 112:3547\u20133553","journal-title":"Circulation"},{"key":"9814_CR16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/eurjpc\/zwac285","volume":"30","author":"Y Li","year":"2023","unstructured":"Li Y, Cao G-y, Jing W-z, Liu J, Liu M (2023) Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990\u2009\u2013\u20092019: findings from 2019 global burden of disease study. Eur J Prev Cardiol 30:276\u2013286","journal-title":"Eur J Prev Cardiol"},{"key":"9814_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/ijerph19010207","volume":"19","author":"L Cium\u0103rnean","year":"2021","unstructured":"Cium\u0103rnean L, Milaciu MV, Negrean V et al (2021) Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly. Int J Environ Res Public Health 19:207","journal-title":"Int J Environ Res Public Health"},{"key":"9814_CR18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cjca.2020.12.004","volume":"37","author":"NR Campbell","year":"2021","unstructured":"Campbell NR, Ordunez P, Giraldo G et al (2021) WHO HEARTS: a global program to reduce cardiovascular disease burden: experience implementing in the Americas and opportunities in Canada. Can J Cardiol 37:744\u2013755","journal-title":"Can J Cardiol"},{"key":"9814_CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.2022.10951","volume":"328","author":"CM Mangione","year":"2022","unstructured":"Mangione CM, Barry MJ, Nicholson WK et al (2022) Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults without cardiovascular disease risk factors: US preventive services task force recommendation statement. JAMA 328:367\u2013374","journal-title":"JAMA"},{"key":"9814_CR20","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.2020.21749","volume":"324","author":"AH Krist","year":"2020","unstructured":"Krist AH, Davidson KW, Mangione CM et al (2020) Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement. JAMA 324:2069\u20132075","journal-title":"JAMA"},{"key":"9814_CR21","doi-asserted-by":"crossref","unstructured":"Haque SE, Khan A, Iqubal A (2024) Mechanism of NLRP3 activation, Associated Cardiovascular complications and Update on its inhibitors acting as cardioprotective agents. The NLRP3 inflammasome, 72 edn. An Attentive Arbiter of Inflammatory Response","DOI":"10.2174\/9789815223941124010007"},{"key":"9814_CR22","doi-asserted-by":"crossref","unstructured":"Cheng W, Li S, Lee T et al (2021) Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis. Biomedicines 2021, 9: 728","DOI":"10.3390\/biomedicines9070728"},{"key":"9814_CR23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1253\/circj.CJ-16-0949","volume":"81","author":"K Fujisue","year":"2017","unstructured":"Fujisue K, Sugamura K, Kurokawa H et al (2017) Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction. Circ J 81:1174\u20131182","journal-title":"Circ J"},{"key":"9814_CR24","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"J-C Tardif","year":"2019","unstructured":"Tardif J-C, Kouz S, Waters DD et al (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381:2497\u20132505","journal-title":"N Engl J Med"},{"key":"9814_CR25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbrc.2017.09.006","volume":"493","author":"N Liu","year":"2017","unstructured":"Liu N, Su H, Zhang Y, Liu Z, Kong J (2017) Cholecalciterol cholesterol emulsion attenuates experimental autoimmune myocarditis in mice via inhibition of the pyroptosis signaling pathway. Biochem Biophys Res Commun 493:422\u2013428","journal-title":"Biochem Biophys Res Commun"},{"key":"9814_CR26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/ijbs.29680","volume":"15","author":"F Yang","year":"2019","unstructured":"Yang F, Qin Y, Wang Y et al (2019) Metformin inhibits the NLRP3 inflammasome via AMPK\/mTOR-dependent effects in diabetic cardiomyopathy. Int J Biol Sci 15:1010","journal-title":"Int J Biol Sci"},{"key":"9814_CR27","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1042\/CS20190585","volume":"133","author":"M Xue","year":"2019","unstructured":"Xue M, Li T, Wang Y et al (2019) Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice. Clin Sci 133:1705\u20131720","journal-title":"Clin Sci"},{"key":"9814_CR28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/mol.116.108100","volume":"92","author":"S Wang","year":"2017","unstructured":"Wang S, Xie X, Lei T et al (2017) Statins attenuate activation of the NLRP3 inflammasome by oxidized LDL or TNF\u03b1 in vascular endothelial cells through a PXR-dependent mechanism. Mol Pharmacol 92:256\u2013264","journal-title":"Mol Pharmacol"},{"key":"9814_CR29","doi-asserted-by":"crossref","first-page":"707336","DOI":"10.3389\/fcvm.2021.707336","volume":"8","author":"F Mu\u00f1oz-C\u00f3rdova","year":"2021","unstructured":"Mu\u00f1oz-C\u00f3rdova F, Hern\u00e1ndez-Fuentes C, Lopez-Crisosto C et al (2021) Novel insights into the pathogenesis of diabetic cardiomyopathy and pharmacological strategies. Front Cardiovasc Med 8:707336","journal-title":"Front Cardiovasc Med"},{"key":"9814_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ctm2.13","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu X, Shi H et al (2020) NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases. Clin Translational Med 10:91\u2013106","journal-title":"Clin Translational Med"},{"key":"9814_CR31","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3889\/oamjms.2021.7541","volume":"9","author":"MM Zein","year":"2021","unstructured":"Zein MM, Mahmoud AT, El Hawary AS, Hegazy N (2021) Cardiovascular diseases Healthy Diet related knowledge among a sample of the General Population in Egypt. Open Access Macedonian J Med Sci 9:1764\u20131771","journal-title":"Open Access Macedonian J Med Sci"},{"key":"9814_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.34172\/ijtmgh.2021.18","volume":"9","author":"DO Mensah","year":"2021","unstructured":"Mensah DO, Simkhada P (2021) Cardiovascular disease among international travellers. Int J Travel Med Global Health 9:107\u2013112","journal-title":"Int J Travel Med Global Health"},{"key":"9814_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41434-020-00197-8","volume":"29","author":"MR Cring","year":"2022","unstructured":"Cring MR, Sheffield VC (2022) Gene therapy and gene correction: targets, progress, and challenges for treating human diseases. Gene Ther 29:3\u201312","journal-title":"Gene Ther"},{"key":"9814_CR34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.yjmcc.2019.03.010","volume":"129","author":"LE Dorn","year":"2019","unstructured":"Dorn LE, Tual-Chalot S, Stellos K, Accornero F (2019) RNA epigenetics and cardiovascular diseases. J Mol Cell Cardiol 129:272\u2013280","journal-title":"J Mol Cell Cardiol"},{"key":"9814_CR35","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1080\/10408398.2017.1341865","volume":"58","author":"MS Campbell","year":"2018","unstructured":"Campbell MS, Fleenor BS (2018) The emerging role of curcumin for improving vascular dysfunction: a review. Crit Rev Food Sci Nutr 58:2790\u20132799","journal-title":"Crit Rev Food Sci Nutr"},{"key":"9814_CR36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/10641963.2013.863322","volume":"36","author":"ZS Talas","year":"2014","unstructured":"Talas ZS, Ozdemir I, Ciftci O, Cakir O, Gulhan MF, Pasaoglu OM (2014) Role of propolis on biochemical parameters in kidney and heart tissues against L-NAME induced oxidative injury in rats. Clin Exp Hypertens 36:492\u2013496","journal-title":"Clin Exp Hypertens"},{"key":"9814_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10641963.2020.1806294","volume":"43","author":"B Ozdemir","year":"2021","unstructured":"Ozdemir B, Gulhan MF, Sahna E, Selamoglu Z (2021) The investigation of antioxidant and anti-inflammatory potentials of apitherapeutic agents on heart tissues in nitric oxide synthase inhibited rats via N\u03c9-nitro-L-arginine methyl ester. Clin Exp Hypertens 43:69\u201376","journal-title":"Clin Exp Hypertens"},{"key":"9814_CR38","unstructured":"Dastan S, Gulhan M, Selamoglu Z, Dastan T (2017) The determination of different effective concentration of ethanolic extract of bee pollen on biochemical analysis in liver, spleen and heart tissues of rainbow trout, Oncorhynchus mykiss (Walbaum, 1792)."},{"key":"9814_CR39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.regpep.2009.08.009","volume":"159","author":"ZS Talas","year":"2010","unstructured":"Talas ZS, Ozdemir I, Gok Y, Ates B, Yilmaz I (2010) Role of selenium compounds on tyrosine hydroxylase activity, adrenomedullin and total RNA levels in hearts of rats. Regul Pept 159:137\u2013141","journal-title":"Regul Pept"},{"key":"9814_CR40","unstructured":"Sevindik M, Ajaz M, \u00d6zdemir B, Akata I, Selamo\u011flu Z (2021) Oxidant\/antioxidant potentials and heavy metal levels of Pisolithus arhizus and its effects on cardiovascular diseases"},{"key":"9814_CR41","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s13770-022-00469-x","volume":"19","author":"L Ahmed","year":"2022","unstructured":"Ahmed L, Al-Massri K (2022) New approaches for enhancement of the efficacy of mesenchymal stem cell-derived exosomes in cardiovascular diseases. Tissue Eng Regenerative Med 19:1129\u20131146","journal-title":"Tissue Eng Regenerative Med"},{"key":"9814_CR42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fbioe.2019.00489","volume":"7","author":"Y Deng","year":"2020","unstructured":"Deng Y, Zhang X, Shen H et al (2020) Application of the nano-drug delivery system in treatment of cardiovascular diseases. Front Bioeng Biotechnol 7:489","journal-title":"Front Bioeng Biotechnol"},{"key":"9814_CR43","doi-asserted-by":"crossref","unstructured":"Pala R, Anju V, Dyavaiah M, Busi S, Nauli SM (2020) Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases. Int J Nanomed, 3741\u20133769","DOI":"10.2147\/IJN.S250872"},{"key":"9814_CR44","doi-asserted-by":"crossref","unstructured":"Baez-Diaz C, Crisostomo V (2023) Large animal models of Cardiovascular Disease: from training to translation. JoVE (Journal of Visualized Experiments, e64983","DOI":"10.3791\/64983-v"},{"key":"9814_CR45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cbf.3173","volume":"34","author":"H-G Tsang","year":"2016","unstructured":"Tsang H-G, Rashdan N, Whitelaw C, Corcoran B, Summers K, MacRae V (2016) Large animal models of cardiovascular disease. Cell Biochem Funct 34:113\u2013132","journal-title":"Cell Biochem Funct"},{"key":"9814_CR46","doi-asserted-by":"crossref","first-page":"dev167","DOI":"10.1242\/dev.167692","volume":"146","author":"IJ Marques","year":"2019","unstructured":"Marques IJ, Lupi E, Mercader N (2019) Model systems for regeneration: zebrafish. Development 146:dev167\u2013692","journal-title":"Development"},{"key":"9814_CR47","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/bph.15473","volume":"179","author":"G Bowley","year":"2022","unstructured":"Bowley G, Kugler E, Wilkinson R et al (2022) Zebrafish as a tractable model of human cardiovascular disease. Br J Pharmacol 179:900\u2013917","journal-title":"Br J Pharmacol"},{"key":"9814_CR48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41569-023-00914-x","volume":"21","author":"M Weinberger","year":"2024","unstructured":"Weinberger M, Riley PR (2024) Animal models to study cardiac regeneration. Nat Reviews Cardiol 21:89\u2013105","journal-title":"Nat Reviews Cardiol"},{"key":"9814_CR49","doi-asserted-by":"crossref","first-page":"e1629","DOI":"10.1002\/wsbm.1629","volume":"16","author":"H Huang","year":"2024","unstructured":"Huang H, Huang GN, Payumo AY (2024) Two decades of heart regeneration research: cardiomyocyte proliferation and beyond. WIREs Mech Disease 16:e1629","journal-title":"WIREs Mech Disease"},{"key":"9814_CR50","doi-asserted-by":"crossref","first-page":"e05635","DOI":"10.7554\/eLife.05635","volume":"4","author":"DM Parichy","year":"2015","unstructured":"Parichy DM (2015) Advancing biology through a deeper understanding of zebrafish ecology and evolution. Elife 4:e05635","journal-title":"Elife"},{"key":"9814_CR51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/291293a0","volume":"291","author":"G Streisinger","year":"1981","unstructured":"Streisinger G, Walker C, Dower N, Knauber D, Singer F (1981) Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature 291:293\u2013296","journal-title":"Nature"},{"key":"9814_CR52","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/CIRCRESAHA.122.320396","volume":"130","author":"JM Gonz\u00e1lez-Rosa","year":"2022","unstructured":"Gonz\u00e1lez-Rosa JM (2022) Zebrafish models of cardiac disease: from fortuitous mutants to precision medicine. Circul Res 130:1803\u20131826","journal-title":"Circul Res"},{"key":"9814_CR53","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/cvr\/cvab214","volume":"118","author":"KM Ross Stewart","year":"2022","unstructured":"Ross Stewart KM, Walker SL, Baker AH, Riley PR, Brittan M (2022) Hooked on heart regeneration: the zebrafish guide to recovery. Cardiovascular Res 118:1667\u20131679","journal-title":"Cardiovascular Res"},{"key":"9814_CR54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4236\/wjcs.2016.611022","volume":"6","author":"M Mohammadnezhad","year":"2016","unstructured":"Mohammadnezhad M, Mangum T, May W, Lucas JJ, Ailson S (2016) Common modifiable and non-modifiable risk factors of cardiovascular disease (CVD) among Pacific countries. World J Cardiovasc Surg 6:153","journal-title":"World J Cardiovasc Surg"},{"key":"9814_CR55","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/biomedicines9060699","volume":"9","author":"PJ Little","year":"2021","unstructured":"Little PJ, Askew CD, Xu S, Kamato D (2021) Endothelial dysfunction and cardiovascular disease: history and analysis of the clinical utility of the relationship. Biomedicines 9:699","journal-title":"Biomedicines"},{"key":"9814_CR56","doi-asserted-by":"crossref","unstructured":"Tsoupras A, Lordan R, Zabetakis I (2019) Inflammation and cardiovascular diseases; in the impact of nutrition and statins on cardiovascular diseases. Elsevier, pp 53\u2013117","DOI":"10.1016\/B978-0-12-813792-5.00003-3"},{"key":"9814_CR57","doi-asserted-by":"crossref","first-page":"105912","DOI":"10.1016\/j.phrs.2021.105912","volume":"173","author":"SK Goswami","year":"2021","unstructured":"Goswami SK, Ranjan P, Dutta RK, Verma SK (2021) Management of inflammation in cardiovascular diseases. Pharmacol Res 173:105912","journal-title":"Pharmacol Res"},{"key":"9814_CR58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2020.02.003","volume":"297","author":"A Wang","year":"2020","unstructured":"Wang A, Dai L, Zhang N et al (2020) Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA. Atherosclerosis 297:74\u201380","journal-title":"Atherosclerosis"},{"key":"9814_CR59","doi-asserted-by":"crossref","unstructured":"Muthalaly RG, Abrahams TB, Nerlekar N et al (2024) Asymptomatic coronary artery disease in ischaemic stroke survivors: a systematic review and meta-analysis. Eur Stroke J, 23969873241231702","DOI":"10.1177\/23969873241231702"},{"key":"9814_CR60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","volume":"119","author":"SA Dick","year":"2016","unstructured":"Dick SA, Epelman S (2016) Chronic heart failure and inflammation: what do we really know? Circul Res 119:159\u2013176","journal-title":"Circul Res"},{"key":"9814_CR61","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","volume":"39","author":"A Polk","year":"2013","unstructured":"Polk A, Vaage-Nilsen M, Vistisen K, Nielsen DL (2013) Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev 39:974\u2013984","journal-title":"Cancer Treat Rev"},{"key":"9814_CR62","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/j.ijcard.2013.12.274","volume":"172","author":"S Rateesh","year":"2014","unstructured":"Rateesh S, Luis SA, Luis CR, Hughes B, Nicolae M (2014) Myocardial infarction secondary to 5-fluorouracil: not an absolute contraindication to rechallenge? Int J Cardiol 172:e331\u2013e333","journal-title":"Int J Cardiol"},{"key":"9814_CR63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4997\/JRCPE.2011.204","volume":"41","author":"R Ducas","year":"2011","unstructured":"Ducas R, Seftel M, Ducas J, Seifer C (2011) Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia. J Royal Coll Physicians Edinb 41:117\u2013118","journal-title":"J Royal Coll Physicians Edinb"},{"key":"9814_CR64","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-133-11-200012050-00012","volume":"133","author":"K Ohnishi","year":"2000","unstructured":"Ohnishi K, Yoshida H, Shigeno K et al (2000) Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med 133:881\u2013885","journal-title":"Ann Intern Med"},{"key":"9814_CR65","doi-asserted-by":"crossref","unstructured":"Economopoulou P, Kotsakis A, Kapiris I, Kentepozidis N (2015) Cancer therapy and cardiovascular risk: focus on bevacizumab. Cancer Manage Res, 133\u2013143","DOI":"10.2147\/CMAR.S77400"},{"key":"9814_CR66","doi-asserted-by":"crossref","first-page":"28982","DOI":"10.3402\/jchimp.v5.28982","volume":"5","author":"MG Meseeha","year":"2015","unstructured":"Meseeha MG, Kolade VO, Attia MN (2015) Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy. J Community Hosp Intern Med Perspect 5:28982","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"9814_CR67","doi-asserted-by":"crossref","first-page":"e87671","DOI":"10.1371\/journal.pone.0087671","volume":"9","author":"Y Xiao","year":"2014","unstructured":"Xiao Y, Yin J, Wei J, Shang Z (2014) Incidence and risk of cardiotoxicity associated with bortezomib in the treatment of cancer: a systematic review and meta-analysis. PLoS ONE 9:e87671","journal-title":"PLoS ONE"},{"key":"9814_CR68","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.2459\/JCM.0b013e328341d0e5","volume":"16","author":"SA Wayangankar","year":"2015","unstructured":"Wayangankar SA, Patel BC, Parekh HD, Holter JL, Lazzara R (2015) High-dose cytosine arabinoside-induced symptomatic bradycardia. J Cardiovasc Med 16:S38\u2013S41","journal-title":"J Cardiovasc Med"},{"key":"9814_CR69","first-page":"e002661","volume":"9","author":"MW Bloom","year":"2016","unstructured":"Bloom MW, Hamo CE, Cardinale D et al (2016) Cancer therapy\u2013related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging. Circulation: Heart Fail 9:e002661","journal-title":"Circulation: Heart Fail"},{"key":"9814_CR70","unstructured":"Druhan L, Fasan O, Copelan OR (2015) Acute heart failure in a patient with acute myeloid leukemia following daunorubicin treatment: a case report. J. Leuk 3"},{"key":"9814_CR71","doi-asserted-by":"crossref","unstructured":"Xu Z, Cang S, Yang T, Liu D (2009) Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy. Hematol Reviews 1","DOI":"10.4081\/hr.2009.e4"},{"key":"9814_CR72","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","volume":"34","author":"TM Suter","year":"2013","unstructured":"Suter TM, Ewer MS (2013) Cancer drugs and the heart: importance and management. Eur Heart J 34:1102\u20131111","journal-title":"Eur Heart J"},{"key":"9814_CR73","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/EDBK_286019","volume":"40","author":"SF Dent","year":"2020","unstructured":"Dent SF, Kikuchi R, Kondapalli L et al (2020) Optimizing cardiovascular health in patients with cancer: a practical review of risk assessment, monitoring, and prevention of cancer treatment\u2013related cardiovascular toxicity. Am Soc Clin Oncol Educational Book 40:501\u2013515","journal-title":"Am Soc Clin Oncol Educational Book"},{"key":"9814_CR74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcha.2015.11.004","volume":"10","author":"MA Mitry","year":"2016","unstructured":"Mitry MA, Edwards JG (2016) Doxorubicin induced heart failure: phenotype and molecular mechanisms. IJC Heart Vasculature 10:17\u201324","journal-title":"IJC Heart Vasculature"},{"key":"9814_CR75","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1161\/CIRCRESAHA.121.318223","volume":"128","author":"VS Hahn","year":"2021","unstructured":"Hahn VS, Zhang KW, Sun L, Narayan V, Lenihan DJ, Ky B (2021) Heart failure with targeted cancer therapies: mechanisms and cardioprotection. Circul Res 128:1576\u20131593","journal-title":"Circul Res"},{"key":"9814_CR76","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","volume":"375","author":"DB Johnson","year":"2016","unstructured":"Johnson DB, Balko JM, Compton ML et al (2016) Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 375:1749\u20131755","journal-title":"N Engl J Med"},{"key":"9814_CR77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1634\/theoncologist.12-7-756","volume":"12","author":"B Moy","year":"2007","unstructured":"Moy B, Goss PE (2007) Lapatinib-associated toxicity and practical management recommendations. Oncologist 12:756\u2013765","journal-title":"Oncologist"},{"key":"9814_CR78","doi-asserted-by":"crossref","unstructured":"Mamoshina P, Rodriguez B, Bueno-Orovio A (2021) Toward a broader view of mechanisms of drug cardiotoxicity. Cell Rep Med 2","DOI":"10.1016\/j.xcrm.2021.100216"},{"key":"9814_CR79","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/hrt.44.3.330","volume":"44","author":"E Grenadier","year":"1980","unstructured":"Grenadier E, Keidar S, Alpan G, Marmor A, Palant A (1980) Prenylamine-induced ventricular tachycardia and syncope controlled by ventricular pacing. Br Heart J 44:330","journal-title":"Br Heart J"},{"key":"9814_CR80","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1584\/jpestics.D18-088","volume":"44","author":"H Katsuta","year":"2019","unstructured":"Katsuta H, Nomura M, Wakita T et al (2019) Discovery of broflanilide, a novel insecticide. J Pesticide Sci 44:120\u2013128","journal-title":"J Pesticide Sci"},{"key":"9814_CR81","doi-asserted-by":"crossref","first-page":"117481","DOI":"10.1016\/j.envpol.2021.117481","volume":"286","author":"M Duan","year":"2021","unstructured":"Duan M, Zhang J, Liu J et al (2021) Toxic effects of broflanilide exposure on development of zebrafish (Danio rerio) embryos and its potential cardiotoxicity mechanism. Environ Pollut 286:117481","journal-title":"Environ Pollut"},{"key":"9814_CR82","first-page":"109439","volume":"261","author":"M Porretti","year":"2022","unstructured":"Porretti M, Arrigo F, Di Bella G, Faggio C (2022) Impact of pharmaceutical products on zebrafish: an effective tool to assess aquatic pollution. Comp Biochem Physiol C: Toxicol Pharmacol 261:109439","journal-title":"Comp Biochem Physiol C: Toxicol Pharmacol"},{"key":"9814_CR83","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.envpol.2017.05.072","volume":"231","author":"H-c Liu","year":"2017","unstructured":"Liu H-c, Chu T-y, Chen L-l, Gui W-j, Zhu G-n (2017) The cardiovascular toxicity of triadimefon in early life stage of zebrafish and potential implications to human health. Environ Pollut 231:1093\u20131103","journal-title":"Environ Pollut"},{"key":"9814_CR84","doi-asserted-by":"crossref","first-page":"126418","DOI":"10.1016\/j.chemosphere.2020.126418","volume":"251","author":"Y Sun","year":"2020","unstructured":"Sun Y, Cao Y, Tong L et al (2020) Exposure to prothioconazole induces developmental toxicity and cardiovascular effects on zebrafish embryo. Chemosphere 251:126418","journal-title":"Chemosphere"},{"key":"9814_CR85","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhu W, Shu F et al (2020) Nd2O3 nanoparticles induce toxicity and cardiac\/cerebrovascular abnormality in zebrafish embryos via the apoptosis pathway. Int J Nanomed, 387\u2013400","DOI":"10.2147\/IJN.S220785"},{"key":"9814_CR86","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.scitotenv.2018.04.012","volume":"634","author":"L Qian","year":"2018","unstructured":"Qian L, Cui F, Yang Y, Liu Y, Qi S, Wang C (2018) Mechanisms of developmental toxicity in zebrafish embryos (Danio rerio) induced by boscalid. Sci Total Environ 634:478\u2013487","journal-title":"Sci Total Environ"},{"key":"9814_CR87","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/4551047a","volume":"455","author":"DR Green","year":"2008","unstructured":"Green DR, Chipuk JE (2008) Stabbed in the BAX. Nature 455:1047\u20131049","journal-title":"Nature"},{"key":"9814_CR88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-010-0709-x","volume":"351","author":"MS Ola","year":"2011","unstructured":"Ola MS, Nawaz M, Ahsan H (2011) Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351:41\u201358","journal-title":"Mol Cell Biochem"},{"key":"9814_CR89","doi-asserted-by":"crossref","first-page":"125941","DOI":"10.1016\/j.chemosphere.2020.125941","volume":"248","author":"K Jia","year":"2020","unstructured":"Jia K, Cheng B, Huang L et al (2020) Thiophanate-methyl induces severe hepatotoxicity in zebrafish. Chemosphere 248:125941","journal-title":"Chemosphere"},{"key":"9814_CR90","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/bdrc.20058","volume":"75","author":"RE Poelmann","year":"2005","unstructured":"Poelmann RE, Gittenberger-de Groot AC (2005) Apoptosis as an instrument in cardiovascular development. Birth Defects Res Part C: Embryo Today: Reviews 75:305\u2013313","journal-title":"Birth Defects Res Part C: Embryo Today: Reviews"},{"key":"9814_CR91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.aquatox.2009.03.001","volume":"93","author":"J Deng","year":"2009","unstructured":"Deng J, Yu L, Liu C et al (2009) Hexabromocyclododecane-induced developmental toxicity and apoptosis in zebrafish embryos. Aquat Toxicol 93:29\u201336","journal-title":"Aquat Toxicol"},{"key":"9814_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2020.02.003","volume":"324","author":"X Shang","year":"2020","unstructured":"Shang X, Ji X, Dang J et al (2020) \u03b1-asarone induces cardiac defects and QT prolongation through mitochondrial apoptosis pathway in zebrafish. Toxicol Lett 324:1\u201311","journal-title":"Toxicol Lett"},{"key":"9814_CR93","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfy044","volume":"163","author":"KA Horzmann","year":"2018","unstructured":"Horzmann KA, Freeman JL (2018) Making waves: new developments in toxicology with the zebrafish. Toxicol Sci 163:5\u201312","journal-title":"Toxicol Sci"},{"key":"9814_CR94","doi-asserted-by":"crossref","first-page":"124753","DOI":"10.1016\/j.chemosphere.2019.124753","volume":"238","author":"H Wang","year":"2020","unstructured":"Wang H, Meng Z, Liu F et al (2020) Characterization of boscalid-induced oxidative stress and neurodevelopmental toxicity in zebrafish embryos. Chemosphere 238:124753","journal-title":"Chemosphere"},{"key":"9814_CR95","doi-asserted-by":"crossref","first-page":"117323","DOI":"10.1016\/j.envpol.2021.117323","volume":"285","author":"K Zhong","year":"2021","unstructured":"Zhong K, Meng Y, Wu J et al (2021) Effect of flupyradifurone on zebrafish embryonic development. Environ Pollut 285:117323","journal-title":"Environ Pollut"},{"key":"9814_CR96","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jbiomech.2018.05.004","volume":"75","author":"Y Wang","year":"2018","unstructured":"Wang Y, Sun H, Wei J, Liu X, Liu T, Fan Y (2018) A mathematical model of human heart including the effects of heart contractility varying with heart rate changes. J Biomech 75:129\u2013137","journal-title":"J Biomech"},{"key":"9814_CR97","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/toxics11010084","volume":"11","author":"T Chen","year":"2023","unstructured":"Chen T, Chen H, Wang A et al (2023) Methyl parathion exposure induces development toxicity and cardiotoxicity in zebrafish embryos. Toxics 11:84","journal-title":"Toxics"},{"key":"9814_CR98","first-page":"427","volume":"20","author":"JC Hallab","year":"2021","unstructured":"Hallab JC, Nim HT, Stolper J et al (2021) Towards spatio-temporally resolved developmental cardiac gene regulatory networks in zebrafish. Brief Funct Genomics 20:427\u2013433","journal-title":"Brief Funct Genomics"},{"key":"9814_CR99","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/ijerph13020229","volume":"13","author":"MM Sekhotha","year":"2016","unstructured":"Sekhotha MM, Monyeki KD, Sibuyi ME (2016) Exposure to agrochemicals and cardiovascular disease: a review. Int J Environ Res Public Health 13:229","journal-title":"Int J Environ Res Public Health"},{"key":"9814_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-016-0217-6","volume":"14","author":"C Chakraborty","year":"2016","unstructured":"Chakraborty C, Sharma AR, Sharma G, Lee S-S (2016) Zebrafish: a complete animal model to enumerate the nanoparticle toxicity. J Nanobiotechnol 14:1\u201313","journal-title":"J Nanobiotechnol"},{"key":"9814_CR101","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3390\/ijms17122123","volume":"17","author":"S Sarmah","year":"2016","unstructured":"Sarmah S, Marrs JA (2016) Zebrafish as a vertebrate model system to evaluate effects of environmental toxicants on cardiac development and function. Int J Mol Sci 17:2123","journal-title":"Int J Mol Sci"},{"key":"9814_CR102","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1063654","volume":"295","author":"C Thisse","year":"2002","unstructured":"Thisse C, Zon LI (2002) Organogenesis\u2013heart and blood formation from the zebrafish point of view. Science 295:457\u2013462","journal-title":"Science"},{"key":"9814_CR103","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/biot.200700247","volume":"3","author":"TH Kim","year":"2008","unstructured":"Kim TH, Shin SY, Choo SM, Cho KH (2008) Dynamical analysis of the calcium signaling pathway in cardiac myocytes based on logarithmic sensitivity analysis. Biotechnol Journal: Healthc Nutr Technol 3:639\u2013647","journal-title":"Biotechnol Journal: Healthc Nutr Technol"},{"key":"9814_CR104","doi-asserted-by":"crossref","unstructured":"Liu HongCui LH, Chu TianYi CT, Chen LiLi CL, Gui WenJun GW and Zhu GuoNian ZG (2017) The cardiovascular toxicity of triadimefon in early life stage of zebrafish and potential implications to human health","DOI":"10.1016\/j.envpol.2017.05.072"},{"key":"9814_CR105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/tox.22227","volume":"32","author":"LS Hsu","year":"2017","unstructured":"Hsu LS, Chiou BH, Hsu TW, Wang CC, Chen SC (2017) The regulation of transcriptome responses in zebrafish embryo exposure to triadimefon. Environ Toxicol 32:217\u2013226","journal-title":"Environ Toxicol"},{"key":"9814_CR106","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.etap.2011.09.002","volume":"32","author":"S Liu","year":"2011","unstructured":"Liu S, Chang J, Zhao Y, Zhu G (2011) Changes of thyroid hormone levels and related gene expression in zebrafish on early life stage exposure to triadimefon. Environ Toxicol Pharmacol 32:472\u2013477","journal-title":"Environ Toxicol Pharmacol"},{"key":"9814_CR107","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1567202613999160517124149","volume":"13","author":"K Maiese","year":"2016","unstructured":"Maiese K (2016) Dissecting the mechanisms of Thrombogenesis and Atherosclerosis for neurodegenerative disorders. Curr Neurovasc Res 13:175\u2013176","journal-title":"Curr Neurovasc Res"},{"key":"9814_CR108","doi-asserted-by":"crossref","unstructured":"Liu P, Wang S, Chang Z, Li L, Xing H, Dong W-F (2021) Combined toxicity of silica nanoparticles and cadmium chloride on the cardiovascular system of zebrafish (Danio rerio) larvae. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 239: 108895","DOI":"10.1016\/j.cbpc.2020.108895"},{"key":"9814_CR109","volume-title":"Neurodegeneration in zebrafish embryos and adults after cadmium exposure","author":"A Monaco","year":"2017","unstructured":"Monaco A, Capriello T, Grimaldi MC, Schiano V, Ferrandino I (2017) Neurodegeneration in zebrafish embryos and adults after cadmium exposure. EJH 61, European journal of histochemistry"},{"key":"9814_CR110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-015-0217-0","volume":"23","author":"C-Y Lin","year":"2016","unstructured":"Lin C-Y, Chiang C-Y, Tsai H-J (2016) Zebrafish and Medaka: new model organisms for modern biomedical research. J Biomed Sci 23:1\u201311","journal-title":"J Biomed Sci"},{"key":"9814_CR111","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.envpol.2019.07.029","volume":"254","author":"R Shen","year":"2019","unstructured":"Shen R, Yu Y, Lan R, Yu R, Yuan Z, Xia Z (2019) The cardiovascular toxicity induced by high doses of gatifloxacin and ciprofloxacin in zebrafish. Environ Pollut 254:112\u2013861","journal-title":"Environ Pollut"},{"key":"9814_CR112","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1007\/s10646-014-1350-3","volume":"23","author":"H Zhen","year":"2014","unstructured":"Zhen H, Wen M, Yang Y et al (2014) Toxic effects of HgCl 2 on activities of SOD, AchE and relative expression of SOD, AChE, CYP1A1 of zebrafish. Ecotoxicology 23:1842\u20131845","journal-title":"Ecotoxicology"},{"key":"9814_CR113","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.dci.2016.02.020","volume":"64","author":"S Brugman","year":"2016","unstructured":"Brugman S (2016) The zebrafish as a model to study intestinal inflammation. Dev Comp Immunol 64:82\u201392","journal-title":"Dev Comp Immunol"},{"key":"9814_CR114","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/gerona\/glu008","volume":"70","author":"A Gesing","year":"2015","unstructured":"Gesing A, Wang F, List EO et al (2015) Expression of apoptosis-related genes in liver-specific growth hormone receptor gene\u2013disrupted mice is sex dependent. Journals Gerontol Ser A: Biomedical Sci Med Sci 70:44\u201352","journal-title":"Journals Gerontol Ser A: Biomedical Sci Med Sci"},{"key":"9814_CR115","doi-asserted-by":"crossref","unstructured":"Feng L, Yang X, Shi Y et al (2018) Co-exposure subacute toxicity of silica nanoparticles and lead acetate on cardiovascular system. Int J Nanomed, 7819\u20137834","DOI":"10.2147\/IJN.S185259"},{"key":"9814_CR116","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1080\/10643389.2023.2174771","volume":"53","author":"Y Yang","year":"2023","unstructured":"Yang Y, Tao Y, Li Z, Cui Y, Zhang J, Zhang Y (2023) Agrochemical-mediated cardiotoxicity in zebrafish embryos\/larvae: what we do and where we go. Crit Rev Environ Sci Technol 53:1662\u20131683","journal-title":"Crit Rev Environ Sci Technol"},{"key":"9814_CR117","doi-asserted-by":"crossref","unstructured":"Hussain MM, Rafi U, Imran A, Rehman MU, Abbas SK (2024) Risk factors Associated with Cardiovascular disorders: risk factors Associated with Cardiovascular disorders. Pakistan BioMedical J, 03\u201310","DOI":"10.54393\/pbmj.v7i02.1034"},{"key":"9814_CR118","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11748-019-01163-x","volume":"67","author":"H Shimizu","year":"2019","unstructured":"Shimizu H, Hirahara N, Motomura N, Miyata H, Takamoto S (2019) Current status of cardiovascular surgery in Japan, 2015 and 2016: analysis of data from Japan cardiovascular surgery database. 4\u2015thoracic aortic surgery. Gen Thorac Cardiovasc Surg 67:751\u2013757","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"9814_CR119","doi-asserted-by":"crossref","first-page":"4","DOI":"10.14797\/mdcj-12-1-4","volume":"12","author":"NB Langer","year":"2016","unstructured":"Langer NB, Argenziano M (2016) Minimally invasive cardiovascular surgery: incisions and approaches. Methodist Debakey Cardiovasc J 12:4","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"9814_CR120","doi-asserted-by":"crossref","unstructured":"Xiong X, Yang X, Liu W, Chu F, Wang P, Wang J (2013) Trends in the treatment of hypertension from the perspective of traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2013","DOI":"10.1155\/2013\/275279"},{"key":"9814_CR121","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","volume":"69","author":"P Hao","year":"2017","unstructured":"Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y (2017) Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol 69:2952\u20132966","journal-title":"J Am Coll Cardiol"},{"key":"9814_CR122","first-page":"60","volume":"19","author":"D Haim","year":"2008","unstructured":"Haim D, Videla LA (2008) Policosanols, protective natural compounds in cardiovascular disease. Agro Food Ind Hi-Tech 19:60","journal-title":"Agro Food Ind Hi-Tech"},{"key":"9814_CR123","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1381612824666180130112652","volume":"24","author":"RV Giglio","year":"2018","unstructured":"Giglio RV, Patti AM, Cicero AF et al (2018) Polyphenols: potential use in the prevention and treatment of cardiovascular diseases. Curr Pharm Design 24:239\u2013258","journal-title":"Curr Pharm Design"},{"key":"9814_CR124","doi-asserted-by":"crossref","first-page":"21138","DOI":"10.3390\/molecules201219753","volume":"20","author":"Y-J Zhang","year":"2015","unstructured":"Zhang Y-J, Gan R-Y, Li S et al (2015) Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules 20:21138\u201321156","journal-title":"Molecules"},{"key":"9814_CR125","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1017\/S0007114515005231","volume":"115","author":"JM Hodgson","year":"2016","unstructured":"Hodgson JM, Prince RL, Woodman RJ et al (2016) Apple intake is inversely associated with all-cause and disease-specific mortality in elderly women. Br J Nutr 115:860\u2013867","journal-title":"Br J Nutr"},{"key":"9814_CR126","first-page":"80","volume":"12","author":"M Sevindik","year":"2021","unstructured":"Sevindik M, \u00d6zdemir B, Braidy N, Akg\u00fcl H, Akata I, Selamo\u011flu Z (2021) Potential cardiogenic effects of poisonous mushrooms. Mantar Dergisi 12:80\u201386","journal-title":"Mantar Dergisi"},{"key":"9814_CR127","unstructured":"Ozdemir I, Selamoglu Z, Ates B, Gok Y, Yilmaz I (2007) Modulation of DMBA-induced biochemical changes by organoselenium compounds in blood of rats"},{"key":"9814_CR128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12011-008-8262-0","volume":"128","author":"Z Selamoglu Talas","year":"2009","unstructured":"Selamoglu Talas Z, Yilmaz I, Ozdemir I, Ates B, Gok Y, Cetinkaya B (2009) Role of synthesized organoselenium compounds on protection of rat erythrocytes from DMBA-induced oxidative stress. Biol Trace Elem Res 128:167\u2013175","journal-title":"Biol Trace Elem Res"},{"key":"9814_CR129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fct.2003.08.002","volume":"42","author":"J Perottoni","year":"2004","unstructured":"Perottoni J, Rodrigues O, Paixao M et al (2004) Renal and hepatic ALA-D activity and selected oxidative stress parameters of rats exposed to inorganic mercury and organoselenium compounds. Food Chem Toxicol 42:17\u201328","journal-title":"Food Chem Toxicol"},{"key":"9814_CR130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/90600472","volume":"9","author":"T Fenner","year":"2004","unstructured":"Fenner T, Schiesser CH (2004) Toward pyridine-fused selenium-containing antioxidants. Molecules 9:472\u2013479","journal-title":"Molecules"},{"key":"9814_CR131","doi-asserted-by":"crossref","unstructured":"Siasos G, Tsigkou V, Kosmopoulos M et al (2018) Mitochondria and cardiovascular diseases\u2014from pathophysiology to treatment. Annals of translational medicine 6","DOI":"10.21037\/atm.2018.06.21"},{"key":"9814_CR132","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jcp.27161","volume":"234","author":"A Bahreyni","year":"2019","unstructured":"Bahreyni A, Avan A, Shabani M et al (2019) Therapeutic potential of A2 adenosine receptor pharmacological regulators in the treatment of cardiovascular diseases, recent progress, and prospective. J Cell Physiol 234:1295\u20131299","journal-title":"J Cell Physiol"},{"key":"9814_CR133","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12265-018-9799-8","volume":"12","author":"J Ni","year":"2019","unstructured":"Ni J, Sun Y, Liu Z (2019) The potential of stem cells and stem cell-derived exosomes in treating cardiovascular diseases. J Cardiovasc Transl Res 12:51\u201361","journal-title":"J Cardiovasc Transl Res"},{"key":"9814_CR134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.biopha.2017.01.060","volume":"88","author":"D Lv","year":"2017","unstructured":"Lv D, Cheng X, Tang L, Jiang M (2017) The cardioprotective effect of total flavonoids on myocardial ischemia\/reperfusion in rats. Biomed Pharmacother 88:277\u2013284","journal-title":"Biomed Pharmacother"},{"key":"9814_CR135","doi-asserted-by":"crossref","unstructured":"Ye B, Chen X, Dai S et al (2019) Emodin alleviates myocardial ischemia\/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. Drug design, development and therapy, pp 975\u2013990","DOI":"10.2147\/DDDT.S195412"},{"key":"9814_CR136","doi-asserted-by":"crossref","unstructured":"Lv DongLing LD, Cheng XiaoHu CX, Tang LingYi TL, Jiang Meng JM (2017) The cardioprotective effect of total flavonoids on myocardial ischemia\/reperfusion in rats","DOI":"10.1016\/j.biopha.2017.01.060"},{"key":"9814_CR137","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ et al (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21:248\u2013255","journal-title":"Nat Med"},{"key":"9814_CR138","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","volume":"15","author":"A Tapia-Abell\u00e1n","year":"2019","unstructured":"Tapia-Abell\u00e1n A, Angosto-Bazarra D, Mart\u00ednez-Banaclocha H et al (2019) MCC950 closes the active conformation of NLRP3 to an inactive state. Nat Chem Biol 15:560\u2013564","journal-title":"Nat Chem Biol"},{"key":"9814_CR139","doi-asserted-by":"crossref","unstructured":"Zhang Q, Wang S, Chen X, Guo H, Ling S, Xu J (2018) Dunye Guanxinning improves acute myocardial ischemia-reperfusion injury by inhibiting neutrophil infiltration and caspase-1 activity. Mediators of Inflammation 2018","DOI":"10.1155\/2018\/4608017"},{"key":"9814_CR140","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1111\/jcmm.13743","volume":"22","author":"H Zhang","year":"2018","unstructured":"Zhang H, Chen X, Zong B et al (2018) Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP 3 inflammasome activation. J Cell Mol Med 22:4437\u20134448","journal-title":"J Cell Mol Med"},{"key":"9814_CR141","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang H, He H, Chen Y et al (2017) Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med 214:3219\u20133238","journal-title":"J Exp Med"},{"key":"9814_CR142","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.biopha.2017.05.033","volume":"91","author":"X Zhang","year":"2017","unstructured":"Zhang X, Du Q, Yang Y et al (2017) The protective effect of Luteolin on myocardial ischemia\/reperfusion (I\/R) injury through TLR4\/NF-\u03baB\/NLRP3 inflammasome pathway. Biomed Pharmacother 91:1042\u20131052","journal-title":"Biomed Pharmacother"},{"key":"9814_CR143","doi-asserted-by":"crossref","unstructured":"Wang YueQiu WY, Li Hui LH, Li Yang LY et al (2019) Coriolus Versicolor alleviates diabetic cardiomyopathy by inhibiting cardiac fibrosis and NLRP3 inflammasome activation","DOI":"10.1002\/ptr.6448"},{"key":"9814_CR144","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jcmm.12915","volume":"21","author":"Y Wang","year":"2017","unstructured":"Wang Y, Yan X, Mi S et al (2017) Naoxintong attenuates Ischaemia\/reperfusion Injury through inhibiting NLRP 3 inflammasome activation. J Cell Mol Med 21:4\u201312","journal-title":"J Cell Mol Med"},{"key":"9814_CR145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000351179","volume":"126","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wu Y, Chen J, Zhao S, Li H (2013) Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation. Cardiology 126:1\u201311","journal-title":"Cardiology"},{"key":"9814_CR146","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/FJC.0000000000000550","volume":"71","author":"Y Han","year":"2018","unstructured":"Han Y, Qiu H, Pei X, Fan Y, Tian H, Geng J (2018) Low-dose sinapic acid abates the pyroptosis of macrophages by downregulation of lncRNA-MALAT1 in rats with diabetic atherosclerosis. J Cardiovasc Pharmacol 71:104\u2013112","journal-title":"J Cardiovasc Pharmacol"},{"key":"9814_CR147","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ijms20020360","volume":"20","author":"X-C Pan","year":"2019","unstructured":"Pan X-C, Liu Y, Cen Y-Y et al (2019) Dual role of triptolide in interrupting the NLRP3 inflammasome pathway to attenuate cardiac fibrosis. Int J Mol Sci 20:360","journal-title":"Int J Mol Sci"},{"key":"9814_CR148","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10557-013-6498-1","volume":"28","author":"B Luo","year":"2014","unstructured":"Luo B, Li B, Wang W et al (2014) Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc Drugs Ther 28:33\u201343","journal-title":"Cardiovasc Drugs Ther"},{"key":"9814_CR149","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/cmdc.201600055","volume":"11","author":"M Cocco","year":"2016","unstructured":"Cocco M, Miglio G, Giorgis M et al (2016) Design, synthesis, and evaluation of acrylamide derivatives as direct NLRP3 inflammasome inhibitors. ChemMedChem 11:1790\u20131803","journal-title":"ChemMedChem"},{"key":"9814_CR150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-018-0692-z","volume":"113","author":"JP Audia","year":"2018","unstructured":"Audia JP, Yang X-M, Crockett ES et al (2018) Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y 12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function. Basic Res Cardiol 113:1\u201315","journal-title":"Basic Res Cardiol"},{"key":"9814_CR151","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00535-016-1238-5","volume":"52","author":"MA Kanak","year":"2017","unstructured":"Kanak MA, Shahbazov R, Yoshimatsu G, Levy MF, Lawrence MC, Naziruddin B (2017) A small molecule inhibitor of NF\u03baB blocks ER stress and the NLRP3 inflammasome and prevents progression of pancreatitis. J Gastroenterol 52:352\u2013365","journal-title":"J Gastroenterol"},{"key":"9814_CR152","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FJC.0000000000000658","volume":"73","author":"S Toldo","year":"2019","unstructured":"Toldo S, Mauro AG, Cutter Z et al (2019) The NLRP3 inflammasome inhibitor, OLT1177 (dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse. J Cardiovasc Pharmacol 73:215\u2013222","journal-title":"J Cardiovasc Pharmacol"},{"key":"9814_CR153","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377:1119\u20131131","journal-title":"N Engl J Med"},{"key":"9814_CR154","doi-asserted-by":"crossref","unstructured":"Mastrocola R, Penna C, Tullio F et al (2016) Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia\/reperfusion injury by activation of RISK and mitochondrial pathways. Oxidative Medicine and Cellular Longevity 2016","DOI":"10.1155\/2016\/5271251"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09814-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09814-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09814-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:04:58Z","timestamp":1738728298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09814-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9814"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09814-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animal was used in current study, so ethical statement is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"904"}}